Article
Restored degradation of the Alzheimer's amyloid-beta peptide by targeting amyloid formation.
Journal of neurochemistry - 1 Mar 2009
Crouch Peter J, Tew Deborah J, Du Tai, Nguyen Diem Ngoc, Caragounis Aphrodite, Filiz Gulay, Blake Rachel E, Trounce Ian A, Soon Cynthia P W, Laughton Katrina, Perez Keyla A, Li Qiao-Xin, Cherny Robert A, Masters Colin L, Barnham Kevin J, White Anthony R
Abstract excerpt
Accumulation of neurotoxic amyloid-beta (Abeta) is central to the pathology of Alzheimer's disease (AD). Elucidating the mechanisms of Abeta accumulation will therefore expedite the development of Abeta-targeting AD therapeutics. We examined activity of an Abeta-degrading protease (matrix metalloprotease 2) to investigate whether biochemical factors consistent with conditions in the AD brain contribute to Abeta...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
